We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
SINNOWA MEDICAL SCIENCE & TECH

Download Mobile App





Quick and Accurate COVID-19 Test Identifies Neutralizing Antibodies to Aid Vaccine Immunity Monitoring

By LabMedica International staff writers
Posted on 06 Jan 2021
Print article
Illustration
Illustration
Researchers have developed a new technology to aid COVID-19 vaccine immunity monitoring with potential for use as an in-home antibody test.

As the COVID-19 vaccine becomes available to the public, immunity monitoring will play an important role in determining whether the vaccine is effective for an individual, and for how long. A new diagnostic test developed by researchers at the University of Alabama (Birmingham, AL, USA) is an accurate and reliable method for determining whether individuals are protected against COVID-19. The technology identifies neutralizing antibodies - those that block the virus from infecting cells. Emerging research suggests neutralizing antibodies offer the best protection against the virus.

The most widely used antibody tests today do not specifically identify neutralizing antibodies. Currently, these neutralizing antibodies can only be measured at a high level of accuracy using complicated and time-consuming laboratory tests not available to the general public. Existing antibody tests use a broad approach to locating antibodies, which attach to very small and distinct pieces of the virus. Current tests can mistake antibodies for other viruses, such as the common cold, for COVID-19 antibodies, leading to possible false-positive results.

To create the new test, the researchers began breaking down the COVID-19 virus into small pieces to identify the exact locations where antibodies attached to the virus. The results were better than the researchers anticipated, with the test detecting 20% more positive cases than the current gold-standard clinical antibody test. The ability to specifically recognize even small amounts of antibodies accurately is an important achievement, according to the researchers.

Immunity to COVID-19 is not anticipated to last forever, and immunity monitoring could continue for several years, even after widespread administration of a vaccine. Clinical trials indicated that COVID-19 vaccines may be remarkably successful; however, even 95% effectiveness will leave millions unprotected. Antibody testing helps determine efficacy and should help indicate whether a person is protected against the virus. The researchers hope to transition the technology to an inexpensive and easy-to-use test that will provide in-home immunity monitoring for the general public.

“The goal of every vaccine is to get the body to produce antibodies, which serve as a first line of defense against the virus,” said Benjamin Larimer, Ph.D., researcher at the University of Alabama at Birmingham, who developed the test. “Tests that specifically detect these antibodies can be used to measure whether a vaccine works, and possibly predict how long its protection will last.”

Related Links:
University of Alabama


Print article

Channels

Molecular Diagnostics

view channel
Image: Blood smear from a P. falciparum culture: several red blood cells have ring stages inside them while close to the center is a schizont and on the left a trophozoite (Photo courtesy of Wikimedia Commons)

Panel of MicroRNAs Differentiates Uncomplicated and Severe Malaria in Children

MicroRNAs (miRNAs), which are rapidly released from damaged tissues into the host fluids, constitute a promising biomarker for the prognosis of severe malaria. MiRNAs comprise a class of about 20 n... Read more

Pathology

view channel
Image: The Leica Bond III stainer is fully automated Immunohistochemical and In Situ Hybridization (IHC and ISH stainer) (Photo courtesy of Leica Biosystems).

Mismatch Repair/Microsatellite Instability Evaluated Using Cytology Effusion Specimens

DNA mismatch repair (MMR) status is routinely assessed in colorectal and endometrial carcinoma as a method of cancer prevention, surveillance in patients with Lynch syndrome and their families, and for... Read more

Industry

view channel
Image: BioProfile FLEX2 Cell Culture Analyzer (Photo courtesy of Nova Biomedical)

Nova Biomedical Adds Sample Retain Collector to BioProfile FLEX2 Cell Culture Analyzer

Nova Biomedical (Waltham, MA, USA) has added a Sample Retain Collector (SRC) for its BioProfile FLEX2 automated cell culture analyzer which measures up to 16 tests including pH, gases, metabolites, osmolality,... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.